Finzony

Indoco Remedies Limited

INDOCO Healthcare
₹ 173.28
-6.79%

Live Market Data

Market Cap₹ 1,599 Cr.
Current Price₹ 173.28
High / Low₹349.8 / 172.1
Stock P/E0.0
Book Value₹123.6
Dividend Yield0.12 %
ROCE0.0 %
ROE0.0 %

About Company

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Industry Segment

Drug Manufacturers - Specialty & Generic

Price Chart

Loading Chart...

Technical Analysis

Technical Outlook

Short TermBearish
Mid TermBearish
Long TermNeutral
Resistance₹339.1000061035156
Support₹173.4600067138672

Valuation Check

Fair Value Assessment
Fair Value

Research Reports

No recent reports available.

Peer Comparison

Related Sector
CompanyPriceP/EM.Cap (Cr)ROE %
FDC LIMITED
FDC
₹319.9524.075,209-
J B CHEMICALS AND PHARMA
JBCHEPHARM
₹2,063.543.4333,131-
SHILPA MEDICARE LTD
SHILPAMED
₹349.0530.926,828-
IPCA LABORATORIES LTD
IPCALAB
₹1,594.544.4940,600-
HIKAL LIMITED
HIKAL
₹156.4-1,929-

Quarterly Results

ParticularsDec 25Sept 25Jun 25Mar 25Dec 24
Total Revenue (Cr)434.34471.83429.08383.89402.45
Net Income (Cr)-29.79-7.93-35.79-40.39-26.39
EPS (₹)-3.2-1-3.940-3.08

Annual Profit & Loss

Particulars20252024202320221970
Total Revenue (Cr)1,641.291,788.221,640.051,503.740
Operating Exp (Cr)1,153.571,063.26903.1803.910
Net Income (Cr)-73.7498.46142.25154.80
EPS (₹)-810.6815.4416.80

Balance Sheet

ParticularsDec 25Sept 25Jun 25Mar 25Dec 24
Total Assets (Cr)-2,508.02-2,429.91-
Total Liabilities (Cr)-1,533.71-1,411.54-
Total Equity (Cr)-979.77-1,022-

Key Ratios Fundamentals

Valuation

P/E Ratio (TTM)
-
Forward P/E
30.94
PEG Ratio
-
Price / Book
1.54
EV / EBITDA
27.34

Profitability

ROE
-
ROA
-
Profit Margin
-6.47%
Operating Margin
-0.11%

Liquidity & Debt

Current Ratio
-
Quick Ratio
-
Debt / Equity
102.50
Total Cash (Cr)
19.32

Price Statistics

Beta
0.31
52W High
349.80
52W Low
185.10
Dividend Yield
0.11%

Pattern Unavailable

Detailed shareholding breakdown is not currently provided by the exchange.